Effects of VDCC antagonists on AP-induced calcium
currents, AHPslow and AP-induced Ca2+
transients. (A) Inward calcium currents recorded in isolated
nodose neurons evoked by a prerecorded AP waveform from a holding
potential of −60 mV. From Left to Right,
control inward current in the presence of 2 mM
[Ca2+]o and in the presence of 10 μM
nifedipine. After reestablishing control conditions, the neuron was
exposed to 1 μM ω-conotoxin-GVIA. The effects of 500 μM cadmium
were recorded in another neuron; the control current for this cell was
similar to the first trace. (B) AHPslow evoked
by a train of four APs (10 Hz) recorded in another nodose neuron. From
Left to Right, AHPslow evoked
in control conditions, in the presence of 100 μM CdCl2,
after washout, in the presence of 500 nM ω-conotoxin-GVIA, and after
washout. (C) AP-induced Ca2+ transients recorded
in two nodose neurons. From Left to
Right, Ca2+ transients evoked by a train of
eight APs in normal Locke solution, and in Locke solution containing 10
μM nifedipine. In another neuron, 1 μM ω-conotoxin-GVIA reduced
the Ca2+ transient ≈50% (see Table 4). APs were evoked
by 2.5-ms, 10-Hz depolarizing current pulses.